US Patent 8481021 IL-1F5 polypeptides
Patent 8481021 was granted and assigned to Amgen on July, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Nov, 2023
Golden AI
Edits made to:
Article (+111 characters)
Article
Patent abstract
The present invention provides compositions and methods relating to IL-1Rrp2 requiring proteins.
Edits on 22 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Blair R Renshaw0
Christopher Gabel0
Jennifer E. Towne0
John E Sims0
Randal R Ketchem0
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08481021 IL-1F5 polypeptides US Patent 8481021 IL-1F5 polypeptides
Infobox
Patent Number
08481021
Patent Number
8481021
Edits on 17 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08481021 IL-1F5 polypeptides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08481021
Date of patent
July 9, 2013
Patent application number
13225326
Date Filed
September 2, 2011
Patent primary examiner
Find more entities like US Patent 8481021 IL-1F5 polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.